215 related articles for article (PubMed ID: 29579332)
21. EDP-938, a novel nucleoprotein inhibitor of respiratory syncytial virus, demonstrates potent antiviral activities in vitro and in a non-human primate model.
Rhodin MHJ; McAllister NV; Castillo J; Noton SL; Fearns R; Kim IJ; Yu J; Blaisdell TP; Panarese J; Shook BC; Or YS; Goodwin B; Lin K
PLoS Pathog; 2021 Mar; 17(3):e1009428. PubMed ID: 33720995
[TBL] [Abstract][Full Text] [Related]
22. Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entry.
Blockus S; Sake SM; Wetzke M; Grethe C; Graalmann T; Pils M; Le Goffic R; Galloux M; Prochnow H; Rox K; Hüttel S; Rupcic Z; Wiegmann B; Dijkman R; Rameix-Welti MA; Eléouët JF; Duprex WP; Thiel V; Hansen G; Brönstrup M; Haid S; Pietschmann T
Antiviral Res; 2020 May; 177():104774. PubMed ID: 32197980
[TBL] [Abstract][Full Text] [Related]
23. Small molecule inhibits respiratory syncytial virus entry and infection by blocking the interaction of the viral fusion protein with the cell membrane.
Tang W; Li M; Liu Y; Liang N; Yang Z; Zhao Y; Wu S; Lu S; Li Y; Liu F
FASEB J; 2019 Mar; 33(3):4287-4299. PubMed ID: 30571312
[TBL] [Abstract][Full Text] [Related]
24. Amiloride inhibits cytokine production in epithelium infected with respiratory syncytial virus.
Mastronarde JG; Monick MM; Gross TJ; Hunninghake GW
Am J Physiol; 1996 Aug; 271(2 Pt 1):L201-7. PubMed ID: 8770057
[TBL] [Abstract][Full Text] [Related]
25. Prodrugs of a 1'-CN-4-Aza-7,9-dideazaadenosine
Mackman RL; Hui HC; Perron M; Murakami E; Palmiotti C; Lee G; Stray K; Zhang L; Goyal B; Chun K; Byun D; Siegel D; Simonovich S; Du Pont V; Pitts J; Babusis D; Vijjapurapu A; Lu X; Kim C; Zhao X; Chan J; Ma B; Lye D; Vandersteen A; Wortman S; Barrett KT; Toteva M; Jordan R; Subramanian R; Bilello JP; Cihlar T
J Med Chem; 2021 Apr; 64(8):5001-5017. PubMed ID: 33835812
[TBL] [Abstract][Full Text] [Related]
26. Antiviral Efficacy of a Respiratory Syncytial Virus (RSV) Fusion Inhibitor in a Bovine Model of RSV Infection.
Jordan R; Shao M; Mackman RL; Perron M; Cihlar T; Lewis SA; Eisenberg EJ; Carey A; Strickley RG; Chien JW; Anderson ML; McEligot HA; Behrens NE; Gershwin LJ
Antimicrob Agents Chemother; 2015 Aug; 59(8):4889-900. PubMed ID: 26055364
[TBL] [Abstract][Full Text] [Related]
27. Antiviral and Immunomodulatory Activity of Silver Nanoparticles in Experimental RSV Infection.
Morris D; Ansar M; Speshock J; Ivanciuc T; Qu Y; Casola A; Garofalo R
Viruses; 2019 Aug; 11(8):. PubMed ID: 31398832
[TBL] [Abstract][Full Text] [Related]
28. Identification of Non-Nucleoside Inhibitors of the Respiratory Syncytial Virus Polymerase Complex.
Jiménez-Somarribas A; Mao S; Yoon JJ; Weisshaar M; Cox RM; Marengo JR; Mitchell DG; Morehouse ZP; Yan D; Solis I; Liotta DC; Natchus MG; Plemper RK
J Med Chem; 2017 Mar; 60(6):2305-2325. PubMed ID: 28245119
[TBL] [Abstract][Full Text] [Related]
29. Oxidant tone regulates IL-8 production in epithelium infected with respiratory syncytial virus.
Mastronarde JG; Monick MM; Hunninghake GW
Am J Respir Cell Mol Biol; 1995 Aug; 13(2):237-44. PubMed ID: 7626291
[TBL] [Abstract][Full Text] [Related]
30. The Interferon Type I/III Response to Respiratory Syncytial Virus Infection in Airway Epithelial Cells Can Be Attenuated or Amplified by Antiviral Treatment.
McCutcheon KM; Jordan R; Mawhorter ME; Noton SL; Powers JG; Fearns R; Cihlar T; Perron M
J Virol; 2016 Feb; 90(4):1705-17. PubMed ID: 26608311
[TBL] [Abstract][Full Text] [Related]
31. Imiquimod suppresses respiratory syncytial virus (RSV) replication via PKA pathway and reduces RSV induced-inflammation and viral load in mice lungs.
Salinas FM; Nebreda AD; Vázquez L; Gentilini MV; Marini V; Benedetti M; Nabaes Jodar MS; Viegas M; Shayo C; Bueno CA
Antiviral Res; 2020 Jul; 179():104817. PubMed ID: 32387475
[TBL] [Abstract][Full Text] [Related]
32. Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.
Fuentes S; Arenas D; Moore MM; Golding H; Khurana S
Vaccine; 2017 Jan; 35(4):694-702. PubMed ID: 27989627
[TBL] [Abstract][Full Text] [Related]
33. Cyclopiazonic acid, an inhibitor of calcium-dependent ATPases with antiviral activity against human respiratory syncytial virus.
Cui R; Wang Y; Wang L; Li G; Lan K; Altmeyer R; Zou G
Antiviral Res; 2016 Aug; 132():38-45. PubMed ID: 27210812
[TBL] [Abstract][Full Text] [Related]
34. Antiviral effect of cimicifugin from Cimicifuga foetida against human respiratory syncytial virus.
Wang KC; Chang JS; Lin LT; Chiang LC; Lin CC
Am J Chin Med; 2012; 40(5):1033-45. PubMed ID: 22928833
[TBL] [Abstract][Full Text] [Related]
35. Discovery of novel benzothienoazepine derivatives as potent inhibitors of respiratory syncytial virus.
Fordyce EAF; Brookes DW; Lise-Ciana C; Coates MS; Hunt SF; Ito K; King-Underwood J; Onions ST; Parra GF; Rapeport G; Sherbukhin V; Stockwell JA; Strong P; Thomas JC; Murray J
Bioorg Med Chem Lett; 2017 May; 27(10):2201-2206. PubMed ID: 28372911
[TBL] [Abstract][Full Text] [Related]
36. The Secretome Profiling of a Pediatric Airway Epithelium Infected with hRSV Identified Aberrant Apical/Basolateral Trafficking and Novel Immune Modulating (CXCL6, CXCL16, CSF3) and Antiviral (CEACAM1) Proteins.
Touzelet O; Broadbent L; Armstrong SD; Aljabr W; Cloutman-Green E; Power UF; Hiscox JA
Mol Cell Proteomics; 2020 May; 19(5):793-807. PubMed ID: 32075873
[TBL] [Abstract][Full Text] [Related]
37. Discovery of methylsulfonyl indazoles as potent and orally active respiratory syncytial Virus(RSV) fusion inhibitors.
Feng S; Li C; Chen D; Zheng X; Yun H; Gao L; Shen HC
Eur J Med Chem; 2017 Sep; 138():1147-1157. PubMed ID: 28772235
[TBL] [Abstract][Full Text] [Related]
38. Targeting Intracellular Ion Homeostasis for the Control of Respiratory Syncytial Virus.
Norris MJ; Malhi M; Duan W; Ouyang H; Granados A; Cen Y; Tseng YC; Gubbay J; Maynes J; Moraes TJ
Am J Respir Cell Mol Biol; 2018 Dec; 59(6):733-744. PubMed ID: 30095982
[TBL] [Abstract][Full Text] [Related]
39. Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study.
DeVincenzo JP; McClure MW; Symons JA; Fathi H; Westland C; Chanda S; Lambkin-Williams R; Smith P; Zhang Q; Beigelman L; Blatt LM; Fry J
N Engl J Med; 2015 Nov; 373(21):2048-58. PubMed ID: 26580997
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of antiviral activity of the new hDHODH inhibitor MEDS433 against respiratory syncytial virus replication.
Luganini A; Sibille G; Pavan M; Mello Grand M; Sainas S; Boschi D; Lolli ML; Chiorino G; Gribaudo G
Antiviral Res; 2023 Nov; 219():105734. PubMed ID: 37852322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
